Factors Predicting Positive Sentinel Lymph Node Biopsy in Clinically Node-Negative Breast Cancer

References

• Halsted WS. I. The results of operations for the cure of cancer of the breast performed at the Johns Hopkins Hospital from June, 1889, to January, 1894. Ann Surg. 1894;20(5):497–555. doi:10.1097/00000658-189407000-00075
   Google Scholar
• Giuliano AE, Jones RC, Brennan M, Statman R. Sentinel lymphadenectomy in breast cancer. J Clin Oncol. 1997;15(6):2345–2350. doi:10.1200/JCO.1997.15.6.2345
   Web of Science ®Google Scholar
• Chintamani. The paradigm shifts in the management of breast cancer—have we finally arrived? Indian J Surg. 2013;75(6):419–423. doi:10.1007/s12262-013-1022-1
   Web of Science ®Google Scholar
• Kelley MC, Hansen N, McMasters KM. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Am J Surg. 2004;188(1):49–61. doi:10.1016/j.amjsurg.2003.10.028
   Web of Science ®Google Scholar
• Veronesi U, Paganelli G, Galimberti V, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet. 1997;349(9069):1864–1867. doi:10.1016/S0140-6736(97)01004-0
   PubMed Web of Science ®Google Scholar
• Gould EA, Winship T, Philbin PH, Kerr HH. Observations on a “sentinel node” in cancer of the parotid. Cancer. 1960;13:77–78. doi:10.1002/1097-0142(196001/02)13:1<77::aid-cncr2820130114>3.0.co;2-d
   PubMed Web of Science ®Google Scholar
• Veronesi U, Paganelli G, Viale G, et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med. 2003;349(6):546–553. doi:10.1056/NEJMoa012782
   PubMed Web of Science ®Google Scholar
• Mahdavi R, Yousefpour N, Abbasvandi F, et al. Intraoperative pathologically-calibrated diagnosis of lymph nodes involved by breast cancer cells based on electrical impedance spectroscopy; a prospective diagnostic human model study. Int J Surg. 2021;96:106166. doi:10.1016/j.ijsu.2021.106166
   Web of Science ®Google Scholar
• Gipponi M, Bassetti C, Canavese G, et al. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients. J Surg Oncol. 2004;85(3):102–111. doi:10.1002/jso.20022
   Web of Science ®Google Scholar
• Deutsch M, Land S, Begovic M, Sharif S. The incidence of arm edema in women with breast cancer randomized on the National Surgical Adjuvant Breast and Bowel Project study B-04 to radical mastectomy versus total mastectomy and radiotherapy versus total mastectomy alone. Int J Radiat Oncol Biol Phys. 2008;70(4):1020–1024. doi:10.1016/j.ijrobp.2007.07.2376
   Web of Science ®Google Scholar
• Bromham N, Schmidt-Hansen M, Astin M, Hasler E, Reed MW. Axillary treatment for operable primary breast cancer. Cochrane Database Syst Rev. 2017;1:CD004561. doi:10.1002/14651858.CD004561.pub3
   Web of Science ®Google Scholar
• McLaughlin SA, Wright MJ, Morris KT, et al. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements. J Clin Oncol. 2008;26(32):5213–5219. doi:10.1200/JCO.2008.16.3725
   Web of Science ®Google Scholar
• Humphrey LL, Helfand M, Chan BK, Woolf SH. Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2002;137(5Part 1):347–360. doi:10.7326/0003-4819-137-5_part_1-200209030-00012
   Web of Science ®Google Scholar
• Iwamoto T, Kumamaru H, Miyata H, et al. Distinct breast cancer characteristics between screen- and self-detected breast cancers recorded in the Japanese Breast Cancer Registry. Breast Cancer Res Treat. 2016;156(3):485–494. doi:10.1007/s10549-016-3770-7
   Web of Science ®Google Scholar
• Niraula S, Biswanger N, Hu P, Lambert P, Decker K. Incidence, characteristics, and outcomes of interval breast cancers compared with screening-detected breast cancers. JAMA Netw Open. 2020;3(9):e2018179. doi:10.1001/jamanetworkopen.2020.18179
   Web of Science ®Google Scholar
• Vassallo P, Wernecke K, Roos N, Peters PE. Differentiation of benign from malignant superficial lymphadenopathy: the role of high-resolution US. Radiology. 1992;183(1):215–220. doi:10.1148/radiology.183.1.1549675
   Web of Science ®Google Scholar
• Choi YJ, Ko EY, Han BK, Shin JH, Kang SS, Hahn SY. High-resolution ultrasonographic features of axillary lymph node metastasis in patients with breast cancer. Breast. 2009;18(2):119–122. doi:10.1016/j.breast.2009.02.004
   Web of Science ®Google Scholar
• Agresti A. Categorical Data Analysis. Hoboken, NJ: John Wiley & Sons, Inc; 2003.
   Google Scholar
• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492
   PubMed Web of Science ®Google Scholar
• Alotaibi RM, Rezk HR, Juliana CI, Guure C. Breast cancer mortality in Saudi Arabia: modelling observed and unobserved factors. PLoS One. 2018;13(10):e0206148. doi:10.1371/journal.pone.0206148
   PubMed Web of Science ®Google Scholar
• Pavlista D, Duskova M, Novotny J, et al. Komplikace disekce axily pro karcinom prsu [Complications of axillary dissection in breast carcinoma]. Ceska Gynekol. 2002;67(6):333–337. Czech.
   Google Scholar
• Dong Y, Feng Q, Yang W, et al. Preoperative prediction of sentinel lymph node metastasis in breast cancer based on radiomics of T2-weighted fat-suppression and diffusion-weighted MRI. Eur Radiol. 2018;28(2):582–591. doi:10.1007/s00330-017-5005-7
   PubMed Web of Science ®Google Scholar
• Viale G, Zurrida S, Maiorano E, et al. Predicting the status of axillary sentinel lymph nodes in 4351 patients with invasive breast carcinoma treated in a single institution. Cancer. 2005;103(3):492–500. doi:10.1002/cncr.20809
   Web of Science ®Google Scholar
• Minami S, Sakimura C, Irie J, Tokai Y, Okubo H, Ohno T. Predictive factors among clinicopathological characteristics for sentinel lymph node metastasis in T1-T2 breast cancer. Cancer Manag Res. 2021;13:215–223. doi:10.2147/CMAR.S284922
   PubMed Web of Science ®Google Scholar
• Olivotto IA, Jackson JS, Mates D, et al. Prediction of axillary lymph node involvement of women with invasive breast carcinoma: a multivariate analysis. Cancer. 1998;83(5):948–955. doi:10.1002/(SICI)1097-0142(19980901)83:5<948::AID-CNCR21>3.0.CO;2-U
   Web of Science ®Google Scholar
• Harden SP, Neal AJ, Al-Nasiri N, Ashley S, Querci Della Rovere G. Predicting axillary lymph node metastases in patients with T1 infiltrating ductal carcinoma of the breast. Breast. 2001;10(2):155–159. doi:10.1054/brst.2000.0220
   Web of Science ®Google Scholar
• Tan LG, Tan YY, Heng D, Chan MY. Predictors of axillary lymph node metastases in women with early breast cancer in Singapore. Singapore Med J. 2005;46(12):693–697.
   Google Scholar
• Kohrt HE, Olshen RA, Bermas HR, et al. New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients. BMC Cancer. 2008;8:66. doi:10.1186/1471-2407-8-66
   Web of Science ®Google Scholar
• Sopik V, Narod SA. The relationship between tumour size, nodal status and distant metastases: on the origins of breast cancer. Breast Cancer Res Treat. 2018;170(3):647–656. doi:10.1007/s10549-018-4796-9
   Web of Science ®Google Scholar
• Fein DA, Fowble BL, Hanlon AL, et al. Identification of women with T1-T2 breast cancer at low risk of positive axillary nodes. J Surg Oncol. 1997;65(1):34–39. doi:10.1002/(sici)1096-9098(199705)65:1<34::aid-jso7>3.0.co;2-p
   Web of Science ®Google Scholar
• Barth A, Craig PH, Silverstein MJ. Predictors of axillary lymph node metastases in patients with T1 breast carcinoma. Cancer. 1997;79(10):1918–1922. doi:10.1002/(SICI)1097-0142(19970515)79:10<1918::AID-CNCR12>3.0.CO;2-Y
   Web of Science ®Google Scholar
• Gann PH, Colilla SA, Gapstur SM, Winchester DJ, Winchester DP. Factors associated with axillary lymph node metastasis from breast carcinoma: descriptive and predictive analyses. Cancer. 1999;86(8):1511–1519. doi:10.1002/(sici)1097-0142(19991015)86:8<511::aid-cncr18>3.0.co;2-d
   Web of Science ®Google Scholar
• Chua B, Ung O, Taylor R, Boyages J. Frequency and predictors of axillary lymph node metastases in invasive breast cancer. ANZ J Surg. 2001;71(12):723–728. doi:10.1046/j.1445-1433.2001.02266.x
   PubMed Web of Science ®Google Scholar
• Ding J, Jiang L, Wu W. Predictive value of clinicopathological characteristics for sentinel lymph node metastasis in early breast cancer. Med Sci Monit. 2017;23:4102–4108. doi:10.12659/msm.902795
   Web of Science ®Google Scholar
• Gajdos C, Tartter PI, Bleiweiss IJ. Lymphatic invasion, tumor size, and age are independent predictors of axillary lymph node metastases in women with T1 breast cancers. Ann Surg. 1999;230(5):692–696. doi:10.1097/00000658-199911000-00012
   Web of Science ®Google Scholar
• Yoshihara E, Smeets A, Laenen A, et al. Predictors of axillary lymph node metastases in early breast cancer and their applicability in clinical practice. Breast. 2013;22(3):357–361. doi:10.1016/j.breast.2012.09.003
   Web of Science ®Google Scholar
• Tucker NS, Cyr AE, Ademuyiwa FO, et al. Axillary ultrasound accurately excludes clinically significant lymph node disease in patients with early stage breast cancer. Ann Surg. 2016;264(6):1098–1102. doi:10.1097/SLA.0000000000001549
   Web of Science ®Google Scholar
• Sato K, Tamaki K, Tsuda H, et al. Utility of axillary ultrasound examination to select breast cancer patients suited for optimal sentinel node biopsy. Am J Surg. 2004;187(6):679–683. doi:10.1016/j.amjsurg.2003.10.012
   Web of Science ®Google Scholar
• Ramjeesingh R, Quan ML, Gardner S, Holloway CM. Prediction of involvement of sentinel and nonsentinel lymph nodes in a Canadian population with breast cancer. Can J Surg. 2009;52(1):23–30.
   Web of Science ®Google Scholar
• Susini T, Nori J, Olivieri S, et al. Predicting the status of axillary lymph nodes in breast cancer: a multiparameter approach including axillary ultrasound scanning. Breast. 2009;18(2):103–108. doi:10.1016/j.breast.2009.02.001
   Web of Science ®Google Scholar